Endosialin/CD248/TEM1 Antibody (458606) [Alexa Fluor® 647]

• Reactivity: Mu
• Applications: ICC/IF
• Clone: 458606
• Clonality: Monoclonal
• Host: Rat
• Conjugate: Alexa Fluor 647

Endosialin/CD248/TEM1 Antibody (458606) [Alexa Fluor® 647] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse Endosialin/CD248
  Val13-Arg693 (predicted)
  Accession # Q91V98
• Specificity: Detects mouse Endosialin/CD248 in direct ELISAs. In direct ELISAs, less than 10% cross-reactivity with recombinant human Endosialin/CD248 is observed.
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Endosialin/CD248/TEM1 Antibody (458606) [Alexa Fluor® 647]

• 2610111G01Rik
• CD164 sialomucin-like 1
• CD164L1
• CD248 antigen
• CD248 antigen, endosialin
• CD248 molecule, endosialin
• CD248
• Endosialin
• MGC119479
• TEM1
• TEM1MGC119478
• Tumor endothelial marker 1

Background

Endosialin, also known as CD248 and tumor endothelial marker 1 (Tem1), is a 165 kDa transmembrane O-glycosylated protein that contains one C-type lectin, one Sushi, one EGF-like domain and a mucin-like stalk in its extracellular domain (ECD). It is expressed on activated perivascular and stromal cells in embyronic and tumor neovasculature but is downregulated in quiescent vasculature. Endosialin regulates pericyte proliferation, migration, and adhesion to matrix Fibronectin and Collagens I and IV. It is also required for lymph node and spleen remodeling during immune responses. Within the ECD, mouse Endosialin shares 76% and 93% aa sequence identity with human and rat Endosialin, respectively.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.